Search research articles
Contact Us
Filters
Showing results (71-80 of 78) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 78 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 9, 2006
Molecular detection of TP53, Ki-Ras and p16INK4A promoter methylation in plasma of patients with colorectal cancer and its association with prognosis. Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study
V Bazan, L Bruno, C Augello, et al.
British Journal of Cancer
|
October 14, 2005
Modulation of 5-fluorouracil as adjuvant systemic chemotherapy in colorectal cancer: the IGCS-COL multicentre, randomised, phase III study
S De Placido, M Lopez, C Carlomagno, et al.
La Clinica Terapeutica
|
August 12, 2006
[Clinical guidelines for the management of gastrointestinal stromal tumors]
M Lopez, A Comandone, V Adamo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 9, 2006
Significance of P16INK4A hypermethylation gene in primary head/neck and colorectal tumors: it is a specific tissue event? Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study
V Agnese, S Corsale, V Calò, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 9, 2006
Detection and quantification of mammaglobin in the blood of breast cancer patients: can it be useful as a potential clinical marker? Preliminary results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study
G Gargano, V Agnese, V Calò, et al.
ESMO Open
|
February 26, 2022
Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario
L Cantini, G Mentrasti, G L Russo, et al.
NPJ Precision Oncology
|
April 10, 2026
The role of the molecular tumor board: learnings from the ROME trial
P Marchetti, G Curigliano, C B Westphalen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1988
Phase III randomized study of fluorouracil, epirubicin, and cyclophosphamide v fluorouracil, doxorubicin, and cyclophosphamide in advanced breast cancer: an Italian multicentre trial
, G Ambrosini, M Balli, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 78) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 78 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 9, 2006
Molecular detection of TP53, Ki-Ras and p16INK4A promoter methylation in plasma of patients with colorectal cancer and its association with prognosis. Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study
V Bazan, L Bruno, C Augello, et al.
British Journal of Cancer
|
October 14, 2005
Modulation of 5-fluorouracil as adjuvant systemic chemotherapy in colorectal cancer: the IGCS-COL multicentre, randomised, phase III study
S De Placido, M Lopez, C Carlomagno, et al.
La Clinica Terapeutica
|
August 12, 2006
[Clinical guidelines for the management of gastrointestinal stromal tumors]
M Lopez, A Comandone, V Adamo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 9, 2006
Significance of P16INK4A hypermethylation gene in primary head/neck and colorectal tumors: it is a specific tissue event? Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study
V Agnese, S Corsale, V Calò, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 9, 2006
Detection and quantification of mammaglobin in the blood of breast cancer patients: can it be useful as a potential clinical marker? Preliminary results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study
G Gargano, V Agnese, V Calò, et al.
ESMO Open
|
February 26, 2022
Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario
L Cantini, G Mentrasti, G L Russo, et al.
NPJ Precision Oncology
|
April 10, 2026
The role of the molecular tumor board: learnings from the ROME trial
P Marchetti, G Curigliano, C B Westphalen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1988
Phase III randomized study of fluorouracil, epirubicin, and cyclophosphamide v fluorouracil, doxorubicin, and cyclophosphamide in advanced breast cancer: an Italian multicentre trial
, G Ambrosini, M Balli, et al.
Page
of 8